- Home
- VTAK vs SXTP Comparison
VTAK vs SXTP Comparison
Compare VTAK & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- SXTP
- Stock Information
- Founded
- VTAK 2002
- SXTP 2010
- Country
- VTAK United States
- SXTP United States
- Employees
- VTAK N/A
- SXTP N/A
- Industry
- VTAK Medical/Dental Instruments
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- VTAK Health Care
- SXTP Health Care
- Exchange
- VTAK Nasdaq
- SXTP Nasdaq
- Market Cap
- VTAK 1.4M
- SXTP 1.6M
- IPO Year
- VTAK 2018
- SXTP 2023
- Fundamental
- Price
- VTAK $0.33
- SXTP $1.26
- Analyst Decision
- VTAK
- SXTP Hold
- Analyst Count
- VTAK 0
- SXTP 1
- Target Price
- VTAK N/A
- SXTP N/A
- AVG Volume (30 Days)
- VTAK 152.4K
- SXTP 723.0K
- Earning Date
- VTAK 11-13-2024
- SXTP 11-14-2024
- Dividend Yield
- VTAK N/A
- SXTP N/A
- EPS Growth
- VTAK N/A
- SXTP N/A
- EPS
- VTAK N/A
- SXTP N/A
- Revenue
- VTAK $399,000.00
- SXTP $462,612.00
- Revenue This Year
- VTAK $637.10
- SXTP $141.35
- Revenue Next Year
- VTAK $177.13
- SXTP $175.16
- P/E Ratio
- VTAK N/A
- SXTP N/A
- Revenue Growth
- VTAK 27.07
- SXTP 128.99
- 52 Week Low
- VTAK $0.31
- SXTP $0.70
- 52 Week High
- VTAK $4.10
- SXTP $18.36
- Technical
- Relative Strength Index (RSI)
- VTAK 34.81
- SXTP 49.15
- Support Level
- VTAK $0.31
- SXTP $1.35
- Resistance Level
- VTAK $0.37
- SXTP $1.74
- Average True Range (ATR)
- VTAK 0.04
- SXTP 0.29
- MACD
- VTAK 0.00
- SXTP -0.02
- Stochastic Oscillator
- VTAK 20.00
- SXTP 18.00
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.